Terms: = Breast cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Treatment
118 results:
1. Cytosolic DNA accumulation promotes breast cancer immunogenicity via a STING-independent pathway.
Zhang J; Dai H; Huo L; Burks JK; McGrail DJ; Lin SY
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37907220
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of breast reconstruction for N2-3M0 stage female breast cancer on breast cancer-specific survival: A population-based propensity score analysis.
Zhao Y; Yan L; Li S; Yang Z; Chai N; Qiu P; Zhang H; He J; Zhou C
Cancer Med; 2023 Oct; 12(20):20287-20298. PubMed ID: 37795774
[TBL] [Abstract] [Full Text] [Related]
3. A proteogenomics data-driven knowledge base of human cancer.
Liao Y; Savage SR; Dou Y; Shi Z; Yi X; Jiang W; Lei JT; Zhang B
Cell Syst; 2023 Sep; 14(9):777-787.e5. PubMed ID: 37619559
[TBL] [Abstract] [Full Text] [Related]
4. Bioinformatics analysis to identify breast cancer-related potential targets and candidate small molecule drugs.
Hong H; Chen H; Zhao J; Qin L; Li H; Huo H; Shi S
Mutat Res; 2023; 827():111830. PubMed ID: 37437506
[TBL] [Abstract] [Full Text] [Related]
5. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Morra A; Schreurs MAC; Andrulis IL; Anton-Culver H; Augustinsson A; Beckmann MW; Behrens S; Bojesen SE; Bolla MK; Brauch H; Broeks A; Buys SS; Camp NJ; Castelao JE; Cessna MH; Chang-Claude J; Chung WK; ; Colonna SV; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Dennis J; Devilee P; Dörk T; Dunning AM; Dwek M; Easton DF; Eccles DM; Eriksson M; Evans DG; Fasching PA; Fehm TN; Figueroa JD; Flyger H; Gabrielson M; Gago-Dominguez M; García-Closas M; García-Sáenz JA; Genkinger J; Grassmann F; Gündert M; Hahnen E; Haiman CA; Hamann U; Harrington PA; Hartikainen JM; Hoppe R; Hopper JL; Houlston RS; Howell A; ; ; Jakubowska A; Janni W; Jernström H; John EM; Johnson N; Jones ME; Kristensen VN; Kurian AW; Lambrechts D; Le Marchand L; Lindblom A; Lubiński J; Lux MP; Mannermaa A; Mavroudis D; Mulligan AM; Muranen TA; Nevanlinna H; Nevelsteen I; Neven P; Newman WG; Obi N; Offit K; Olshan AF; Park-Simon TW; Patel AV; Peterlongo P; Phillips KA; Plaseska-Karanfilska D; Polley EC; Presneau N; Pylkäs K; Rack B; Radice P; Rashid MU; Rhenius V; Robson M; Romero A; Saloustros E; Sawyer EJ; Schmutzler RK; Schuetze S; Scott C; Shah M; Smichkoska S; Southey MC; Tapper WJ; Teras LR; Tollenaar RAEM; Tomczyk K; Tomlinson I; Troester MA; Vachon CM; van Veen EM; Wang Q; Wendt C; Wildiers H; Winqvist R; Ziogas A; Hall P; Pharoah PDP; Adank MA; Hollestelle A; Schmidt MK; Hooning MJ
Cancer Med; 2023 Aug; 12(15):16142-16162. PubMed ID: 37401034
[TBL] [Abstract] [Full Text] [Related]
6. Association of hospital-level factors with utilization of sentinel lymph node biopsy in patients with early-stage vulvar cancer.
Bercow AS; Rauh-Hain JA; Melamed A; Mazina V; Growdon WB; Del Carmen MG; Goodman A; Bouberhan S; Randall T; Sisodia R; Bregar A; Eisenhauer EL; Minami C; Molina G
Gynecol Oncol; 2023 Feb; 169():47-54. PubMed ID: 36508758
[TBL] [Abstract] [Full Text] [Related]
7. Association of Hormone Therapy With Depression During Menopause in a Cohort of Danish Women.
Wium-Andersen MK; Jørgensen TSH; Halvorsen AH; Hartsteen BH; Jørgensen MB; Osler M
JAMA Netw Open; 2022 Nov; 5(11):e2239491. PubMed ID: 36318208
[TBL] [Abstract] [Full Text] [Related]
8. Circulating LncRNAs landscape as potential biomarkers in breast cancer.
Pourramezan Z; Attar FA; Yusefpour M; Azizi M; Oloomi M
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1722. PubMed ID: 36274054
[TBL] [Abstract] [Full Text] [Related]
9. Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial.
Huang DT; McCreary EK; Bariola JR; Minnier TE; Wadas RJ; Shovel JA; Albin D; Marroquin OC; Kip KE; Collins K; Schmidhofer M; Wisniewski MK; Nace DA; Sullivan C; Axe M; Meyers R; Weissman A; Garrard W; Peck-Palmer OM; Wells A; Bart RD; Yang A; Berry LR; Berry S; Crawford AM; McGlothlin A; Khadem T; Linstrum K; Montgomery SK; Ricketts D; Kennedy JN; Pidro CJ; Nakayama A; Zapf RL; Kip PL; Haidar G; Snyder GM; McVerry BJ; Yealy DM; Angus DC; Seymour CW
JAMA Netw Open; 2022 Jul; 5(7):e2220957. PubMed ID: 35834252
[TBL] [Abstract] [Full Text] [Related]
10. The Persistence of Poverty and its Impact on cancer Diagnosis, treatment and Survival.
Papageorge MV; Woods AP; de Geus SWL; Ng SC; McAneny D; Tseng JF; Kenzik KM; Sachs TE
Ann Surg; 2023 Jun; 277(6):995-1001. PubMed ID: 35796386
[TBL] [Abstract] [Full Text] [Related]
11. Added value of repeat sentinel lymph node biopsy in FDG-PET/CT node-negative patients with ipsilateral breast cancer recurrence.
Haarsma R; van Loevezijn AA; Donswijk ML; Scholten AN; Vrancken Peeters MTFD; van Duijnhoven FH
Breast Cancer Res Treat; 2022 Aug; 194(3):617-627. PubMed ID: 35727380
[TBL] [Abstract] [Full Text] [Related]
12. T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis.
Omarini C; Piacentini F; Sperduti I; Cerma K; Barbolini M; Canino F; Nasso C; Isca C; Caggia F; Dominici M; Moscetti L
BMC Cancer; 2022 Jun; 22(1):623. PubMed ID: 35672679
[TBL] [Abstract] [Full Text] [Related]
13. BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in breast cancer.
Wang S; Liu X; Yang M; Yuan D; Ye K; Qu X; Wang X
Dis Markers; 2022; 2022():2760432. PubMed ID: 35493295
[TBL] [Abstract] [Full Text] [Related]
14. Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-breast cancer Drug Targets and Prognostic Markers.
Fang L; Liu Q; Cui H; Zheng Y; Wu C
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456460
[TBL] [Abstract] [Full Text] [Related]
15. Internal Mammary Node Irradiation in Patients With Node-Positive Early breast cancer: Fifteen-Year Results From the Danish breast cancer Group Internal Mammary Node Study.
Thorsen LBJ; Overgaard J; Matthiessen LW; Berg M; Stenbygaard L; Pedersen AN; Nielsen MH; Overgaard M; Offersen BV;
J Clin Oncol; 2022 Dec; 40(36):4198-4206. PubMed ID: 35394824
[TBL] [Abstract] [Full Text] [Related]
16. Retrospective analysis of VES-13 questionnaires in the Senior Women's breast cancer Clinic at Sunnybrook Health Sciences, Toronto, Ontario, Canada.
Zereshkian A; Khan BM; Cao X; Henry-Noel N; Menjak I; Mehta R; Bristow B; Trudeau M; Neve M; Norris M; Pasetka M; Rice K; McCullock F; Wright F; Szumacher E
J Geriatr Oncol; 2022 May; 13(4):541-544. PubMed ID: 35125335
[TBL] [Abstract] [Full Text] [Related]
17. Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature.
Raffone A; Travaglino A; Raimondo D; Neola D; Maletta M; Santoro A; Insabato L; Casadio P; Fanfani F; Zannoni GF; Zullo F; Seracchioli R; Mollo A
Gynecol Oncol; 2022 Apr; 165(1):192-197. PubMed ID: 35078650
[TBL] [Abstract] [Full Text] [Related]
18. Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without cancer.
Chavez-MacGregor M; Lei X; Zhao H; Scheet P; Giordano SH
JAMA Oncol; 2022 Jan; 8(1):69-78. PubMed ID: 34709356
[TBL] [Abstract] [Full Text] [Related]
19. Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation.
Choi JI; Khan AJ; Powell SN; McCormick B; Lozano AJ; Del Rosario G; Mamary J; Liu H; Fox P; Gillespie E; Braunstein LZ; Mah D; Cahlon O
Radiother Oncol; 2021 Dec; 165():142-151. PubMed ID: 34688807
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma.
Raffone A; Travaglino A; Raimondo D; Neola D; Renzulli F; Santoro A; Insabato L; Casadio P; Zannoni GF; Zullo F; Mollo A; Seracchioli R
Gynecol Oncol; 2021 Aug; 162(2):401-406. PubMed ID: 34088515
[TBL] [Abstract] [Full Text] [Related]
[Next]
